Rb Capital Management, LLC Pfizer Inc Transaction History

Rb Capital Management, LLC

$407 Million
Q3 2024

A detailed history of Rb Capital Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rb Capital Management, LLC holds 12,870 shares of PFE stock, worth $342,599. This represents 0.09% of its overall portfolio holdings.

Number of Shares

12,870

Previous 13,184 2.38%

Holding current value

$342,599

Previous $368,000 1.09%

% of portfolio

0.09%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$27.7 - $31.39 $8,697 - $9,856	-314 Reduced 2.38%	12,870 $372,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $2,323 - $2,723	-92 Reduced 0.69%	13,184 $368,000
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $123,081 - $141,336	4,754 Added 55.79%	13,276 $368,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $73,764 - $95,812	-2,823 Reduced 24.88%	8,522 $245,000
Q3 2023 Nov 15, 2023	BUY	$32.09 - $37.51 $4,620 - $5,401	144 Added 1.29%	11,345 $376,000
Q2 2023 Dec 11, 2023	SELL	$36.12 - $41.79 $5,201 - $6,017	-144 Reduced 1.27%	11,201 $410,000
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $77,477 - $89,639	2,145 Added 23.69%	11,201 $410,000
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $25,603 - $33,332	650 Added 7.73%	9,056 $369,000
Q4 2022 Jan 10, 2023	BUY	$41.75 - $54.5 $6,930 - $9,047	166 Added 2.01%	8,406 $431,000
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $80,912 - $98,773	1,849 Added 28.93%	8,240 $361,000
Q2 2022 Jul 14, 2022	BUY	$46.53 - $55.17 $43,970 - $52,135	945 Added 17.35%	6,391 $335,000
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $15,600 - $19,331	341 Added 6.68%	5,446 $282,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $10,577 - $15,680	-256 Reduced 4.78%	5,105 $301,000
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $36,070 - $46,335	-919 Reduced 14.63%	5,361 $231,000
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $718 - $813	-20 Reduced 0.32%	6,280 $246,000
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $13,228 - $14,919	-395 Reduced 5.9%	6,300 $228,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $7,597 - $9,661	227 Added 3.51%	6,695 $246,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $205,359 - $240,933	6,468 New	6,468 $238,000
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $225,056 - $273,026	-7,472 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $201,968 - $288,568	7,472 New	7,472 $246,000
Q3 2019 Oct 10, 2019	SELL	$32.49 - $42.13 $152,118 - $197,252	-4,682 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $173,140 - $194,396	4,682 New	4,682 $203,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $194,789 - $236,268	-5,651 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $18,369 - $19,584	-557 Reduced 8.97%	5,651 $205,000
Q1 2018 Apr 19, 2018	SELL	$31.91 - $37.02 $15,699 - $18,213	-492 Reduced 7.34%	6,208 $220,000
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $498 - $529	-15 Reduced 0.22%	6,700 $243,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $208,165 - $229,317	6,715	6,715 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rb Capital Management, LLC with notifications on news.

Account

Rb Capital Management, LLC Pfizer Inc Transaction History